Related Experiment Video
Updated: Aug 18, 2026

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
Published on: September 24, 2020
The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells
Hsin-Ling Hsu1, Bo Shi, Ronald B Gartenhaus
1Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine and the Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
Abstract:
Multiple copies in T-cell maligancy (MCT-1) is a putative oncogene initially identified in a human T-cell lymphoma. Forced expression of MCT-1 has recently been shown to induce cell transformation and proliferation, as well as to activate survival-related PI-3K/AKT pathways protecting cells from apoptosis. MCT-1 protein is stabilized in response to DNA damage. The impact of MCT-1 overexpression on DNA damage response remains unknown. Here, we show that MCT-1 deregulates cell cycle checkpoints. The phosphorylation of genomic stabilizers H2AX and NBS1 are enhanced in MCT-1-overexpressing cells. Forced expression of MCT-1 significantly increases the number of DNA damage-induced foci involving gamma-H2AX and 53BP1. In MCT-1-overexpressing cells, the proportion of S-phase cell population is preferentially increased after exposure to gamma-irradiation compared to controls. Knockdown of endogenous MCT-1 using an siRNA approach attenuates the H2AX phosphorylation and the G1/S checkpoint defect. Furthermore, MCT-1 is capable of transforming immortalized human mammary epithelial cells and promoting genomic instability. These data shed light on the role of MCT-1 in the cellular response to DNA damage and its involvement in malignant transformation.
Insights
Multiple copies in T-cell malignancy (MCT-1) oncogene drives cell transformation and genomic instability. It deregulates cell cycle checkpoints and DNA damage response, promoting cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Multiple copies in T-cell malignancy (MCT-1) is a putative oncogene identified in T-cell lymphoma.
- MCT-1 overexpression induces cell transformation, proliferation, and activates PI-3K/AKT survival pathways.
- MCT-1 protein stabilizes in response to DNA damage, but its role in DNA damage response is unknown.
Purpose of the Study:
- To investigate the impact of MCT-1 overexpression on DNA damage response and cell cycle regulation.
- To determine MCT-1's role in malignant transformation and genomic instability.
Main Methods:
- Overexpression and knockdown (siRNA) of MCT-1 in human cell lines.
- Analysis of DNA damage markers (gamma-H2AX, NBS1, 53BP1 foci).
- Cell cycle analysis (flow cytometry) after gamma-irradiation.
- Transformation assays in immortalized human mammary epithelial cells.
Main Results:
- MCT-1 overexpression deregulates cell cycle checkpoints, enhancing H2AX and NBS1 phosphorylation.
- MCT-1 increases DNA damage-induced foci (gamma-H2AX, 53BP1) and S-phase population post-irradiation.
- MCT-1 knockdown attenuates H2AX phosphorylation and G1/S checkpoint defects.
- MCT-1 transforms human mammary epithelial cells and promotes genomic instability.
Conclusions:
- MCT-1 plays a critical role in deregulating the DNA damage response and cell cycle checkpoints.
- MCT-1 contributes to malignant transformation and genomic instability.
- Targeting MCT-1 may offer therapeutic strategies for T-cell malignancies and other cancers.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

